Stada-Mabxience Bevacizumab Is Latest To Receive EU Nod
As Riemser’s Thiotepa And Teva Inhalers Also Endorsed By CHMP
Stada and Mabxience have received an endorsement from the EMA for their partnered bevacizumab biosimilar rival to Avastin. Meanwhile, Riemser’s thiotepa generic and two Teva inhalers have also received positive opinions from the CHMP.
